
Ivan A. Greene
Examiner (ID: 427)
| Most Active Art Unit | 1619 |
| Art Unit(s) | 1619 |
| Total Applications | 729 |
| Issued Applications | 119 |
| Pending Applications | 106 |
| Abandoned Applications | 523 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17988722
[patent_doc_number] => 20220354759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => HAIR TREATMENT METHOD
[patent_app_type] => utility
[patent_app_number] => 17/760537
[patent_app_country] => US
[patent_app_date] => 2020-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3772
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17760537
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/760537 | HAIR TREATMENT METHOD | Oct 7, 2020 | Pending |
Array
(
[id] => 18018873
[patent_doc_number] => 20220370372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => BISPHOSPHONATE LOADED STARCH NANOPARTICLE
[patent_app_type] => utility
[patent_app_number] => 17/761057
[patent_app_country] => US
[patent_app_date] => 2020-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4472
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761057
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/761057 | BISPHOSPHONATE LOADED STARCH NANOPARTICLE | Sep 24, 2020 | Pending |
Array
(
[id] => 17944414
[patent_doc_number] => 20220331431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => COMPOSITIONS AND METHODS OF SUPPRESSING AVERSIVENESS OF PHARMACEUTICALS AND INGESTIBLE MATERIALS
[patent_app_type] => utility
[patent_app_number] => 17/641853
[patent_app_country] => US
[patent_app_date] => 2020-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10092
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17641853
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/641853 | COMPOSITIONS AND METHODS OF SUPPRESSING AVERSIVENESS OF PHARMACEUTICALS AND INGESTIBLE MATERIALS | Sep 8, 2020 | Abandoned |
Array
(
[id] => 16720256
[patent_doc_number] => 20210087403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => PIGMENTS
[patent_app_type] => utility
[patent_app_number] => 17/009305
[patent_app_country] => US
[patent_app_date] => 2020-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9484
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17009305
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/009305 | PIGMENTS | Aug 31, 2020 | Pending |
Array
(
[id] => 17945845
[patent_doc_number] => 20220332862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => POLY[ALPHA-CYANOACRYLATE] HYDROLYZATE AND PREPARATION METHOD AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/640480
[patent_app_country] => US
[patent_app_date] => 2020-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6977
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17640480
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/640480 | POLY[ALPHA-CYANOACRYLATE] HYDROLYZATE AND PREPARATION METHOD AND APPLICATION THEREOF | Aug 20, 2020 | Pending |
Array
(
[id] => 16466819
[patent_doc_number] => 20200368356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => CORE-SHELL STRUCTURE, PREPARATION, MEDICINE FOR EXTERNAL APPLICATION, TAPE AGENT AND COSMETIC PRODUCT
[patent_app_type] => utility
[patent_app_number] => 16/990634
[patent_app_country] => US
[patent_app_date] => 2020-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17288
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16990634
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/990634 | Core-shell structure, preparation, medicine for external application, tape agent and cosmetic product | Aug 10, 2020 | Issued |
Array
(
[id] => 16581357
[patent_doc_number] => 20210015759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => CANNABINOID COMPOSITIONS AND PROCESSES FOR MAKING SAME
[patent_app_type] => utility
[patent_app_number] => 16/932699
[patent_app_country] => US
[patent_app_date] => 2020-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16932699
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/932699 | CANNABINOID COMPOSITIONS AND PROCESSES FOR MAKING SAME | Jul 16, 2020 | Abandoned |
Array
(
[id] => 16596989
[patent_doc_number] => 20210023520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => PRODUCTION OF NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 16/931939
[patent_app_country] => US
[patent_app_date] => 2020-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3245
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16931939
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/931939 | PRODUCTION OF NANOPARTICLES | Jul 16, 2020 | Abandoned |
Array
(
[id] => 17836282
[patent_doc_number] => 20220273587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => ALKALIZATION OF URINARY BLADDER WALL PRIOR TO TREATMENT WITH INTRAVESICAL HEPARIN AND ALKALINIZED LIDOCAINE TO ENHANCE RELIEF OF BLADDER PAIN SYMPTOMS
[patent_app_type] => utility
[patent_app_number] => 17/627044
[patent_app_country] => US
[patent_app_date] => 2020-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11169
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627044
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/627044 | ALKALIZATION OF URINARY BLADDER WALL PRIOR TO TREATMENT WITH INTRAVESICAL HEPARIN AND ALKALINIZED LIDOCAINE TO ENHANCE RELIEF OF BLADDER PAIN SYMPTOMS | Jul 13, 2020 | Abandoned |
Array
(
[id] => 16627337
[patent_doc_number] => 20210045990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => DISPERSIBLE POWDER AND COSMETIC
[patent_app_type] => utility
[patent_app_number] => 16/925478
[patent_app_country] => US
[patent_app_date] => 2020-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16925478
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/925478 | DISPERSIBLE POWDER AND COSMETIC | Jul 9, 2020 | Abandoned |
Array
(
[id] => 16570757
[patent_doc_number] => 20210009763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => HYDROGEL INCLUSION COMPLEX INCLUDING PHYSIOLOGICALLY ACTIVE MATERIAL BOUND TO THERMOSENSITIVE POLY(PHOSPHAZENE) BY HOST-GUEST INTERACTION USING BETA-CYCLODEXTRIN AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/906028
[patent_app_country] => US
[patent_app_date] => 2020-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13162
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16906028
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/906028 | HYDROGEL INCLUSION COMPLEX INCLUDING PHYSIOLOGICALLY ACTIVE MATERIAL BOUND TO THERMOSENSITIVE POLY(PHOSPHAZENE) BY HOST-GUEST INTERACTION USING BETA-CYCLODEXTRIN AND USE THEREOF | Jun 18, 2020 | Abandoned |
Array
(
[id] => 18323750
[patent_doc_number] => 20230121878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => WHOLE-CELL CONSTITUENT TRANSPORT SYSTEM AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/913978
[patent_app_country] => US
[patent_app_date] => 2020-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17493
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17913978
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/913978 | WHOLE-CELL CONSTITUENT TRANSPORT SYSTEM AND APPLICATION THEREOF | Jun 15, 2020 | Pending |
Array
(
[id] => 17805750
[patent_doc_number] => 20220257585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => HYALURONIC ACID-BASED OPHTHALMIC DRUG DELIVERY SYSTEM, AND METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 17/618611
[patent_app_country] => US
[patent_app_date] => 2020-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7092
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17618611
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/618611 | HYALURONIC ACID-BASED OPHTHALMIC DRUG DELIVERY SYSTEM, AND METHOD FOR PRODUCING SAME | Jun 8, 2020 | Pending |
Array
(
[id] => 16686652
[patent_doc_number] => 20210069127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => Multi-Dose Concentrated Liquid Diphenhydramine HCl Compositions and Packaged Multi-Dose Liquid Diphenhydramine HCl Formulations
[patent_app_type] => utility
[patent_app_number] => 16/896259
[patent_app_country] => US
[patent_app_date] => 2020-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16896259
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/896259 | Multi-Dose Concentrated Liquid Diphenhydramine HCl Compositions and Packaged Multi-Dose Liquid Diphenhydramine HCl Formulations | Jun 8, 2020 | Abandoned |
Array
(
[id] => 16311071
[patent_doc_number] => 20200289809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => FUNCTIONAL MEMBER AND METHOD OF FABRICATING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/890172
[patent_app_country] => US
[patent_app_date] => 2020-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3269
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16890172
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/890172 | FUNCTIONAL MEMBER AND METHOD OF FABRICATING THE SAME | Jun 1, 2020 | Abandoned |
Array
(
[id] => 16297578
[patent_doc_number] => 20200283301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => HIGH ABSORPTION MINERALS
[patent_app_type] => utility
[patent_app_number] => 16/884161
[patent_app_country] => US
[patent_app_date] => 2020-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24743
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16884161
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/884161 | HIGH ABSORPTION MINERALS | May 26, 2020 | Abandoned |
Array
(
[id] => 16296285
[patent_doc_number] => 20200282008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => COMPOSITIONS AND METHODS FOR LONG TERM RELEASE OF GONADOTROPIN-RELEASING HORMONE (GnRH) ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/880309
[patent_app_country] => US
[patent_app_date] => 2020-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12658
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16880309
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/880309 | COMPOSITIONS AND METHODS FOR LONG TERM RELEASE OF GONADOTROPIN-RELEASING HORMONE (GnRH) ANTAGONISTS | May 20, 2020 | Abandoned |
Array
(
[id] => 17748048
[patent_doc_number] => 20220226251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => COMPOSITIONS OF PROTEINS WITH DIPEPTIDES AS STABILISING AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/611899
[patent_app_country] => US
[patent_app_date] => 2020-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7451
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17611899
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/611899 | COMPOSITIONS OF PROTEINS WITH DIPEPTIDES AS STABILISING AGENTS | May 14, 2020 | Pending |
Array
(
[id] => 17212960
[patent_doc_number] => 20210346296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => A BIOLOGICALLY ACTIVE SUBSTANCE UNIFORMLY DISPERSED MICROSPHERE AND A SUSTAINED RELEASE FORMULATION COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/259371
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17259371
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/259371 | A BIOLOGICALLY ACTIVE SUBSTANCE UNIFORMLY DISPERSED MICROSPHERE AND A SUSTAINED RELEASE FORMULATION COMPRISING THE SAME | May 7, 2020 | Abandoned |
Array
(
[id] => 17684907
[patent_doc_number] => 20220192199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => METHOD FOR REMOVING BIOFILM
[patent_app_type] => utility
[patent_app_number] => 17/604138
[patent_app_country] => US
[patent_app_date] => 2020-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 254
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17604138
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/604138 | METHOD FOR REMOVING BIOFILM | Apr 27, 2020 | Abandoned |